HUTCHMED (China) Ltd (HCM)
17.93
+0.67
(+3.88%)
USD |
NASDAQ |
Jun 21, 16:00
17.96
+0.03
(+0.17%)
Pre-Market: 20:00
HUTCHMED Total Liabilities (Quarterly): 536.39M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 536.39M |
| June 30, 2023 | 497.48M |
| June 30, 2023 | 497.48M |
| December 31, 2022 | 392.58M |
| June 30, 2022 | 342.48M |
| June 30, 2022 | 342.48M |
| June 30, 2021 | 259.19M |
| June 30, 2021 | 259.19M |
| March 31, 2021 | 228.72M |
| June 30, 2020 | 158.51M |
| June 30, 2020 | 158.51M |
| June 30, 2019 | 122.18M |
| June 30, 2019 | 122.18M |
| March 31, 2019 | 138.94M |
| June 30, 2018 | 120.10M |
| June 30, 2018 | 120.10M |
| December 31, 2017 | 112.97M |
| June 30, 2017 | 133.20M |
| June 30, 2017 | 133.20M |
| December 31, 2016 | 138.38M |
| Date | Value |
|---|---|
| June 30, 2016 | 123.68M |
| June 30, 2016 | 123.68M |
| December 31, 2015 | 127.32M |
| September 30, 2015 | 119.18M |
| June 30, 2015 | 106.30M |
| June 30, 2015 | 106.30M |
| December 31, 2014 | 112.88M |
| June 30, 2014 | 98.35M |
| June 30, 2014 | 98.35M |
| December 31, 2013 | 80.83M |
| June 30, 2013 | 77.82M |
| June 30, 2013 | 77.82M |
| December 31, 2012 | 77.52M |
| June 30, 2012 | 121.03M |
| June 30, 2012 | 121.03M |
| December 31, 2011 | 117.44M |
| December 31, 2010 | 91.12M |
| June 30, 2010 | 69.81M |
| June 30, 2010 | 69.81M |
| December 31, 2009 | 52.45M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
122.18M
Minimum
Jun 2019
536.39M
Maximum
Dec 2023
301.34M
Average
259.19M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| Global Pharmatech Inc | -- |
| Sino Biopharmaceutical Ltd | 3.588B |
| Pharmaron Beijing Co Ltd | 1.420B |
| Regencell Bioscience Holdings Ltd | 0.3126M |
| Prenetics Global Ltd | 40.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.280B |
| Shareholders Equity (Quarterly) | 730.54M |
| Debt to Equity Ratio | 0.1086 |
| Current Ratio | 2.722 |
| Net Debt Paydown Yield | -0.85% |